Literature DB >> 11373098

Prognostic and predictive factors in primary breast cancer and their role in patient management: The Nottingham Breast Team.

R S Rampaul1, S E Pinder, C W Elston, I O Ellis.   

Abstract

Breast cancer is the most common carcinoma amongst women in the Western world, yet there are now encouraging signs that improvements in mortality may be a realistic target. Increasing breast awareness amongst women due to better health education can lead to earlier clinical detection. In addition, population screening with mammography can achieve a significant improvement in survival. With significant changes in the range and type of therapeutic options available for patients with breast cancer, there is now a trend towards patients exercising their right in management and therapeutic decisions. All these developments highlight the increasing importance of prognostic and predictive factors in the management of patients with breast cancer. In this review we will discuss current prognostic and predictive factors with particular emphasis on those of relevance in routine histopathology, especially with respect to their clinical applications. Copyright Harcourt Publishers Limited.

Entities:  

Mesh:

Year:  2001        PMID: 11373098     DOI: 10.1053/ejso.2001.1114

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  25 in total

1.  Targeting DNA replication before it starts: Cdc7 as a therapeutic target in p53-mutant breast cancers.

Authors:  Sara Rodriguez-Acebes; Ian Proctor; Marco Loddo; Alex Wollenschlaeger; Mohammed Rashid; Mary Falzon; A Toby Prevost; Richard Sainsbury; Kai Stoeber; Gareth H Williams
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen.

Authors:  Victor Piana de Andrade; Helenice Gobbi
Journal:  Virchows Arch       Date:  2004-10-08       Impact factor: 4.064

3.  Comprehensive breast cancer adjuvant digital summary.

Authors:  Jacqueline Ming Liu; Hsiao Wei Wu; Chui Mei Tiu; Ling Ming Tseng; Sang Hue Yen; Cheng Ying Shiau; Chieh Lan; Anna Fen Yau Li
Journal:  J Digit Imaging       Date:  2006-09       Impact factor: 4.056

4.  [Expression of activated leukocyte cell adhesion molecule in breast cancer. Predictability of the response to taxane-free chemotherapy].

Authors:  E Kilic; K Milde-Langosch; V Müller; R Wirtz; M Ihnen
Journal:  Pathologe       Date:  2008-11       Impact factor: 1.011

5.  Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer.

Authors:  Daxun Piao; Tao Jiang; Gavin Liu; Baosheng Wang; Jin Xu; Anlong Zhu
Journal:  Mol Biol Rep       Date:  2011-06-14       Impact factor: 2.316

Review 6.  Role of hormone receptors and HER2 as prospective molecular markers for breast cancer: An update.

Authors:  Swati Sucharita Mohanty; Chita Ranjan Sahoo; Rabindra Nath Padhy
Journal:  Genes Dis       Date:  2020-12-17

7.  GRP-induced up-regulation of Hsp72 promotes CD16+/94+ natural killer cell binding to colon cancer cells causing tumor cell cytolysis.

Authors:  Lauren Taglia; Damien Matusiak; Richard V Benya
Journal:  Clin Exp Metastasis       Date:  2008-03-19       Impact factor: 5.150

8.  Expression and possible prognostic role of MAGE-A4, NY-ESO-1, and HER-2 antigens in women with relapsing invasive ductal breast cancer: retrospective immunohistochemical study.

Authors:  Daniela Bandić; Antonio Juretić; Bozena Sarcević; Viktor Separović; Mirjana Kujundzić-Tiljak; Tvrtko Hudolin; Giulio C Spagnoli; Dinko Cović; Mirko Samija
Journal:  Croat Med J       Date:  2006-02       Impact factor: 1.351

9.  Tumor stromal vascular endothelial growth factor A is predictive of poor outcome in inflammatory breast cancer.

Authors:  Hugo Arias-Pulido; Nabila Chaher; Yun Gong; Clifford Qualls; Jake Vargas; Melanie Royce
Journal:  BMC Cancer       Date:  2012-07-19       Impact factor: 4.430

10.  Cell-cycle-phase progression analysis identifies unique phenotypes of major prognostic and predictive significance in breast cancer.

Authors:  M Loddo; S R Kingsbury; M Rashid; I Proctor; C Holt; J Young; S El-Sheikh; M Falzon; K L Eward; T Prevost; R Sainsbury; K Stoeber; G H Williams
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.